Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunityVivian Goodell, James Waisman, Lupe G Salazar, et al.
Vaccines|February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast CancerWilliam R Gwin, Lupe G Salazar, James Y Dai, et al.
Cancer Medicine|September 3, 2021
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experienceArjun Gupta, Omar Khalid, Cassadie Moravek, et al.
Abdominal Radiology (New York)|November 30, 2025
Prospective pilot evaluation of dark borosilicate oral contrast media for the evaluation of the stomach and small bowel using CTAchille Mileto, Akitoshi Inoue, Payam Mohammadinejad, et al.
Investigational New Drugs|March 5, 2024
A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancerAndrew H Ko, Andrew L Coveler, Benjamin L Schlechter, et al.
Analytical Chemistry|October 4, 2013
New generation of ensemble-decision aliquot ranking based on simplified microfluidic components for large-capacity trapping of circulating tumor cellsMengxia Zhao, Wyatt C Nelson, Bingchuan Wei, et al.
Gynecologic Oncology|October 3, 2024
Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancerJohn B Liao, Nikita S Jejurikar, Katie M Hitchcock-Bernhardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2015
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer PatientsFabian Birzele, Edgar Voss, Adam Nopora, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancerMary L Disis, Danelle R Wallace, Theodore A Gooley, et al.
Pancreas|October 2, 2023
Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic AdenocarcinomaAndrew L Coveler, Venu G Pillarisetty, Wui-Jin Koh, et al.
Pageof 6